RESUMO
Sigma-1 receptor (S1R) is detected in different cell types and can regulate intracellular signaling pathways. S1R plays a role in the pathomechanism of diseases and the regulation of neurotransmitters. Fluvoxamine can bind to S1R and reduce the serotonin uptake of neurons and platelets. We therefore hypothesized that platelets express S1R, which can modify platelet function. The expression of the SIGMAR1 gene in rat platelets was examined with a reverse transcription polymerase chain reaction and a quantitative polymerase chain reaction. The receptor was also visualized by immunostaining and confocal laser scanning microscopy. The effect of S1R agonist PRE-084 on the eicosanoid synthesis of isolated rat platelets and ADP- and AA-induced platelet aggregation was examined. S1R was detected in rat platelets both at gene and protein levels. Pretreatment with PRE-084 of resting platelets induced elevation of eicosanoid synthesis. The rate of elevation in thromboxane B2 and prostaglandin D2 synthesis was similar, but the production of prostaglandin E2 was higher. The concentration-response curve showed a sigmoidal form. The most effective concentration of the agonist was 2 µM. PRE-084 increased the quantity of cyclooxygenase-1 as detected by ELISA. PRE-084 also elevated the ADP- and AA-induced platelet aggregation. S1R of platelets might regulate physiological or pathological functions.
Assuntos
Plaquetas , Agregação Plaquetária , Difosfato de Adenosina/farmacologia , Animais , Plaquetas/metabolismo , Eicosanoides/metabolismo , Eicosanoides/farmacologia , Humanos , Prostaglandinas/metabolismo , Prostaglandinas/farmacologia , RatosRESUMO
BACKGROUND AND PURPOSE: The blood-brain barrier (BBB) restricts drug penetration to the brain preventing effective treatment of patients suffering from brain tumours. Intra-arterial injection of short-chain alkylglycerols (AGs) opens the BBB and increases delivery of molecules to rodent brain parenchyma in vivo. The mechanism underlying AG-mediated modification of BBB permeability is still unknown. Here, we have tested the effects of AGs on barrier properties of cultured brain microvascular endothelial cells. EXPERIMENTAL APPROACH: The effects of two AGs, 1-O-pentylglycerol and 2-O-hexyldiglycerol were examined using an in vitroâ BBB model consisting of primary cultures of rat brain endothelial cells, co-cultured with rat cerebral glial cells. Integrity of the paracellular, tight junction-based, permeation route was analysed by functional assays, immunostaining for junctional proteins, freeze-fracture electron microscopy, and analysis of claudin-claudin trans-interactions. KEY RESULTS: AG treatment (5 min) reversibly reduced transendothelial electrical resistance and increased BBB permeability for fluorescein accompanied by changes in cell morphology and immunostaining for claudin-5 and ß-catenin. These short-term changes were not accompanied by alterations of inter-endothelial tight junction strand complexity or the trans-interaction of claudin-5. CONCLUSION AND IMPLICATIONS: AG-mediated increase in brain endothelial paracellular permeability was short, reversible and did not affect tight junction strand complexity. Redistribution of junctional proteins and alterations in the cell shape indicate the involvement of the cytoskeleton in the action of AGs. These data confirm the results from in vivo studies in rodents characterizing AGs as adjuvants that transiently open the BBB.
Assuntos
Barreira Hematoencefálica/fisiologia , Encéfalo/metabolismo , Claudina-5/farmacologia , Células Endoteliais/metabolismo , Glicerol/análogos & derivados , Glicerol/farmacologia , Junções Íntimas/efeitos dos fármacos , Animais , Barreira Hematoencefálica/ultraestrutura , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Citoesqueleto , Células Endoteliais/efeitos dos fármacos , Glicerol/farmacocinética , Células HEK293 , Humanos , Microscopia Eletrônica de Transmissão , Permeabilidade/efeitos dos fármacos , Ratos , Ratos WistarRESUMO
Tight junctions (TJs) of the cerebral endothelial cells play a crucial role in the regulation of BBB permeability under physiological, as well as pathological conditions. The regulation of the junctional proteins is under a complex control. In these regulatory processes signalling molecules, some of them localized to the TJ, play an important role. Among the best characterized second messengers which regulate TJ function are the cyclic nucleotides, which, as shown in our experiments, as well, decrease paracellular permeability. Another important signalling molecule involved in TJ regulation is protein kinase C, which may affect differently the formation of TJ and the function of mature TJ. Further signalling molecules known to regulate paracellular permeability are G-proteins, both conventional and small G-proteins, MAP kinases and other protein kinases. Much of our knowledge concerning second messenger regulation of TJ arises fon the study of epithelial cells of different origin, mostly from kidney, therefore the specific regulation of the junctional complex of the BBB still remains to be elucidated.
Assuntos
Barreira Hematoencefálica/metabolismo , Transdução de Sinais/fisiologia , Junções Íntimas/metabolismo , Animais , AMP Cíclico/metabolismo , Humanos , Óxido Nítrico/metabolismo , PermeabilidadeRESUMO
Necrotizing enterocolitis (NEC) is the most common acquired gastrointestinal emergency in neonates. We have developed an animal model of NEC in asphyxiated newborn pigs and investigated the effects of asphyxia on blood flow in superior mesenteric artery and abdominal aorta, cardiovascular data, arterial acid-base and blood gas parameters, and endothelial cytoskeletal structure in mesenteric microvasculature. Anesthetized, mechanically ventilated newborn pigs were included in two groups: piglets underwent severe asphyxia, and sham-operated control animals. A cardiovascular and metabolic failure developed in asphyxiated piglets approximately 1 h after the induction: severe hypotension and bradyarrhythmia were seen and significant reductions of the blood flow were measured in the superior mesenteric artery and abdominal aorta during the critical phase. Rearrangement of cytoskeletal actin structure corresponding to enhanced vascular permeability was seen with bodipy phallacidin in mesenterial endothelium of asphyxiated piglets after a 24-h recovery period. In conclusion, severe vasomotor changes during asphyxia may result in mesenteric endothelial dysfunction implicated in increased vascular permeability, edema formation, and development of NEC in asphyxiated piglets.
Assuntos
Asfixia/complicações , Enterocolite Necrosante/fisiopatologia , Intestinos/irrigação sanguínea , Isquemia , Circulação Esplâncnica/fisiologia , Animais , Animais Recém-Nascidos , Doenças Cardiovasculares/etiologia , Doenças Cardiovasculares/fisiopatologia , Enterocolite Necrosante/etiologia , Feminino , Intestinos/patologia , Masculino , Modelos Animais , SuínosRESUMO
We previously found that the production of adrenomedullin (AM) is one magnitude higher in cerebral endothelial cells (CECs) than in the peripheral endothelium and the AM concentration in the cerebral circulation is significantly higher than in other tested parts of the circulation. We also showed that CECs express AM receptors, and AM as an autocrine hormone is important to regulate the intracellular cAMP level in CECs. Further we reported that acute AM treatment has cAMP-like effects on specific BBB functions: AM decreased endothelial fluid phase endocytosis, activated the P-glycoprotein, increased transendothelial electrical resistance (TEER) and reduced endothelial permeability for sodium fluorescein, which suggests a tightening of intercellular junctions. In the present study, we found chronic AM exposure also increased TEER. In contrast, we could not detect significant effect of AM on the expression of tight junction proteins (claudin-1, occludin and zonula occludens-1). While not affecting expression of tight junction proteins, chronic AM treatment may influence the localization of these proteins which has been reported to correlate with functional changes of the BBB without a change in protein expression.
Assuntos
Barreira Hematoencefálica/efeitos dos fármacos , Encéfalo/metabolismo , Proteínas de Membrana/metabolismo , Peptídeos/administração & dosagem , Junções Íntimas/metabolismo , Adrenomedulina , Animais , Células Cultivadas , Circulação Cerebrovascular , Claudina-1 , Relação Dose-Resposta a Droga , Esquema de Medicação , Impedância Elétrica , Endotélio Vascular/efeitos dos fármacos , Endotélio Vascular/fisiologia , Ocludina , Fosfoproteínas/metabolismo , Ratos , Ratos Wistar , Proteína da Zônula de Oclusão-1RESUMO
Adrenomedullin is a peptide hormone with multifunctional biological properties. Its most characteristic effects are the regulation of circulation and the control of fluid and electrolyte homeostasis through peripheral and central nervous system actions. Although adrenomedullin is a vasodilator of cerebral vasculature, and it may be implicated in the pathomechanism of cerebrovascular diseases, the source of adrenomedullin in the cerebral circulation has not been investigated thus far. We measured the secretion of adrenomedullin by radioimmunoassay and detected adrenomedullin mRNA expression by Northern blot analysis in primary cultures of rat cerebral endothelial cells (RCECs), pericytes and astrocytes. We also investigated the expression of specific adrenomedullin receptor components by reverse transcriptase-polymerase chain reaction and intracellular cAMP concentrations in RCECs and pericytes. RCECs had approximately one magnitude higher adrenomedullin production (135 +/- 13 fmol/10(5) cells per 12 h; mean +/- SD, n = 10) compared to that previously reported for other cell types. RCECs secreted adrenomedullin mostly at their luminal cell membrane. Adrenomedullin production was not increased by thrombin, lipopolysaccharide or cytokines, which are known inducers of adrenomedullin release in peripheral endothelial cells, although it was stimulated by astrocyte-derived factors. Pericytes had moderate, while astrocytes had very low basal adrenomedullin secretion. In vivo experiments showed that adrenomedullin plasma concentration in the jugular vein of rats was approximately 50% higher than that in the carotid artery or in the vena cava. Both RCECs and pericytes, which are potential targets of adrenomedullin in cerebral microcirculation, expressed adrenomedullin receptor components, and exhibited a dose-dependent increase in intracellular cAMP concentrations after exogenous adrenomedullin administration. Antisense oligonucleotide treatment significantly reduced adrenomedullin production by RCECs and tended to decrease intraendothelial cAMP concentrations. These findings may suggest an important autocrine and paracrine role for adrenomedullin in the regulation of cerebral circulation and blood-brain barrier functions. Cerebral endothelial cells are a potential source of adrenomedullin in the central nervous system, where adrenomedullin can also be involved in the regulation of neuroendocrine functions.
Assuntos
Barreira Hematoencefálica/fisiologia , Encéfalo/citologia , Endotélio/citologia , Endotélio/metabolismo , Peptídeos/genética , Adrenomedulina , Animais , Encéfalo/irrigação sanguínea , Encéfalo/metabolismo , AMP Cíclico/metabolismo , Expressão Gênica , Oligonucleotídeos Antissenso/farmacologia , Peptídeos/sangue , Pericitos/metabolismo , RNA Mensageiro/análise , Radioimunoensaio , Ratos , Ratos Wistar , Reação em Cadeia da Polimerase Via Transcriptase ReversaRESUMO
Adrenomedullin (AM) is an important vasodilator in cerebral circulation, and cerebral endothelial cells are a major source of AM. This in vitro study aimed to determine the AM-induced changes in blood-brain barrier (BBB) functions. AM administration increased, whereas AM antisense oligonucleotide treatment decreased transendothelial electrical resistance. AM incubation decreased BBB permeability for sodium fluorescein (mol. wt 376 Da) but not for Evan's blue albumin (mol. wt 67 kDa), and it also attenuated fluid-phase endocytosis. AM treatment resulted in functional activation of P-glycoprotein efflux pump in vitro. Our results indicate that AM as an autocrine mediator plays an important role in the regulation of BBB properties of the cerebral endothelial cells.
Assuntos
Barreira Hematoencefálica/efeitos dos fármacos , Fragmentos de Peptídeos/farmacologia , Peptídeos/metabolismo , Vasodilatadores/farmacologia , Adrenomedulina , Albuminas/farmacocinética , Animais , Comunicação Autócrina/fisiologia , Barreira Hematoencefálica/fisiologia , Corantes/farmacocinética , Impedância Elétrica , Endotélio Vascular/efeitos dos fármacos , Endotélio Vascular/metabolismo , Azul Evans/farmacocinética , Corantes Fluorescentes/farmacocinética , Técnicas In Vitro , Ratos , Ratos Wistar , Rodamina 123/farmacocinéticaRESUMO
The central nervous system requires an effective autoregulation of cerebral circulation in order to meet the critical and unusual demands of the brain. In addition, cerebral microvessels has a unique feature, the formation of the blood-brain barrier, which contributes to the stability of the brain parenchymal microenvironment. Many factors are known to be involved in the regulation of cerebral circulation and blood-brain barrier functions. In the last few years a new potential candidate, adrenomedullin, a hypotensive peptide was added to this list. Adrenomedullin has a potent vasodilator effect on the cerebral vasculature, and it may be implicated in the pathologic mechanism of cerebrovascular diseases. In this review, we describe current knowledge about the origin and possible role of adrenomedullin in the regulation of cerebral circulation and blood-brain barrier functions.
Assuntos
Circulação Cerebrovascular/fisiologia , Peptídeos/fisiologia , Adrenomedulina , Animais , Barreira Hematoencefálica , Transtornos Cerebrovasculares/metabolismo , Transtornos Cerebrovasculares/patologia , Humanos , Peptídeos/sangue , Receptores de Adrenomedulina , Receptores de Peptídeos/fisiologiaRESUMO
A hydrophobic, fibrillogenic peptide fragment of human prion protein (PrP106-126) had in vitro toxicity to neurons expressing cellular prion protein (PrP(C)). In this study, we proved that primary cultures of mouse cerebral endothelial cells (MCEC) express PrP(C). Incubation of MCEC with PrP106-126 (25-200 microM) caused a dose-dependent toxicity assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, lactate dehydrogenase release, bis-benzimide staining for nuclear morphology, and trypan blue exclusion test. Pentosan polysulphate (50-100 microg/ml), a drug effective in scrapie prophylaxis, dose-dependently attenuated the injury. MCEC cultures from mice homogenous for the disrupted PrP gene were resistant to the toxicity of PrP106-126. In conclusion, cerebral endothelium expressing PrP(C) may be directly damaged during spongiform encephalopathies.
Assuntos
Encéfalo/citologia , Endotélio/citologia , Fragmentos de Peptídeos/toxicidade , Príons , Príons/toxicidade , Sequência de Aminoácidos , Animais , Western Blotting , Encéfalo/enzimologia , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Endotélio/enzimologia , Inibidores Enzimáticos/farmacologia , Corantes Fluorescentes , L-Lactato Desidrogenase/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Dados de Sequência Molecular , Poliéster Sulfúrico de Pentosana/farmacologia , Fragmentos de Peptídeos/antagonistas & inibidores , Príons/antagonistas & inibidores , Sais de Tetrazólio , TiazóisRESUMO
1. Effects of pentosan polysulfate (PPS) and the structurally related sulfated polyanions dextran sulfate, fucoidan, and heparin on the scavenger receptor-mediated and fluidphase endocytosis in GP8 immortalized rat brain endothelial cells were investigated. 2. Using 1,1'-dioctadecyl-3,3,3,3'-tetramethylindocarboxyamine perchlorate-labeled acetylated low-density lipoprotein (DiI-AcLDL), we found a binding site with high affinity and low binding capacity, and another one with low affinity and high binding capacity. Increasing ligand concentrations could not saturate DiI-AcLDL uptake. DiI-AcLDL uptake, but not binding, was sensitive to pretreatment with filipin, an inhibitor of caveola formation. 3. PPS (20-200 microg/ml) significantly reduced the binding of DiI-AcLDL after coincubation for 3 hr, though this effect was less expressed after 18 hr. Among other polyanions, only fucoidan decreased the DiI-AcLDL binding after 3 hr, whereas dextran sulfate significantly increased it after 18 hr. PPS treatment induced an increase in DiI-AcLDL uptake, whereas other polysulfated compounds caused a significant reduction. 4. Fluid-phase endocytosis determined by the accumulation of Lucifer yellow was concentration and time dependent in GP8 cells. Coincubation with PPS or other sulfated polyanions could not significantly alter the rate of Lucifer yellow uptake. 5. In conclusion. PPS decreased the binding and increased the uptake of DiI-AcLDL in cerebral endothelial cells, an effect not mimicked by the other polyanions investigated.
Assuntos
Endocitose/fisiologia , Endotélio Vascular/fisiologia , Proteínas de Membrana , Poliéster Sulfúrico de Pentosana/farmacologia , Receptores Imunológicos/fisiologia , Receptores de Lipoproteínas , Animais , Transporte Biológico , Linhagem Celular Transformada , Circulação Cerebrovascular , Endocitose/efeitos dos fármacos , Endotélio Vascular/citologia , Endotélio Vascular/efeitos dos fármacos , Isoquinolinas/farmacocinética , Cinética , Metilaminas/farmacocinética , Ratos , Receptores Imunológicos/efeitos dos fármacos , Receptores Depuradores , Receptores Depuradores Classe BRESUMO
The effect of serine protease inhibitor 4-(2-aminoethyl)benzenesulfonyl fluoride (AEBSF) was investigated on the prevention of tumor-necrosis-factor-alpha (TNF-alpha)-induced blood-brain barrier opening. TNF-alpha (10,000 IU) was injected intracarotidly to newborn pigs pretreated with 0, 2.4, 4.8, 9.6 and 19.2 mg/kg AEBSF (n = 6 in each group). AEBSF dose-dependently inhibited the TNF-alpha-induced increase in the blood-brain barrier permeability for sodium fluorescein (MW = 376) in all of the five brain regions examined, while only 19.2 mg/kg AEBSF could significantly (P < 0.05) decrease the change in Evan's blue-albumin (MW = 67,000) transport in two regions. In conclusion, AEBSF attenuates vasogenic brain edema formation.
Assuntos
Barreira Hematoencefálica/efeitos dos fármacos , Edema Encefálico/prevenção & controle , Inibidores de Serina Proteinase/farmacologia , Sulfonas/farmacologia , Fator de Necrose Tumoral alfa/farmacologia , Animais , Animais Recém-Nascidos , Barreira Hematoencefálica/fisiologia , Encéfalo/metabolismo , Relação Dose-Resposta a Droga , Interações Medicamentosas , Azul Evans/farmacocinética , Feminino , Fluoresceína/farmacocinética , Masculino , SuínosAssuntos
Anti-Inflamatórios não Esteroides/farmacocinética , Poliéster Sulfúrico de Pentosana/farmacocinética , Doenças Priônicas/metabolismo , Animais , Anti-Inflamatórios não Esteroides/uso terapêutico , Camundongos , Poliéster Sulfúrico de Pentosana/uso terapêutico , Doenças Priônicas/tratamento farmacológico , Distribuição TecidualRESUMO
Resuscitation in pediatric emergency and some neurological interventions may result in ischemia reperfusion-induced cerebral injuries. Histamine is one of the well established mediators of cerebral swelling and H1- and H2-receptor antagonists could prevent the development of ischemic brain edema. In the present study, time-dependent changes in the blood-brain barrier (BBB) permeability were investigated in the cerebral cortex of male Wistar rats 1, 2, 4, 8, and 16 h after the beginning of post-ischemic reperfusion. Cerebral ischemia-reperfusion evoked by the 4-vessel occlusion model resulted in significant (p < 0.05) elevations in BBB permeability for albumin, but not for sodium fluorescein. Pre-treatment with a new intracellular histamine receptor antagonist could not prevent ischemic brain edema formation in that model. We conclude that experimental studies could help us to reveal the therapeutic role of histamine receptor antagonists during ischemic brain edema.
Assuntos
Edema Encefálico/etiologia , Edema Encefálico/prevenção & controle , Isquemia Encefálica/complicações , Antagonistas dos Receptores Histamínicos/farmacologia , Éteres Fenílicos/farmacologia , Traumatismo por Reperfusão/prevenção & controle , Animais , Barreira Hematoencefálica/efeitos dos fármacos , Antagonistas dos Receptores Histamínicos/farmacocinética , Masculino , Éteres Fenílicos/farmacocinética , Ratos , Ratos Wistar , Traumatismo por Reperfusão/complicações , Fatores de TempoRESUMO
Pancreatic encephalopathy is a severe complication of acute pancreatitis. Proinflammatory cytokines may play a role in the development of multi-organ failure during pancreatitis. In the present study, we measured the changes in the blood-brain barrier (BBB) permeability concomitantly with the determination of serum tumor necrosis factor (TNF) and interleukin-6 (IL-6) levels in rats before, as well as 6, 24 and 48 h after the beginning of intraductal taurocholic acid-induced acute pancreatitis. Cytokine concentrations were measured in bioassays with specific cell lines (WEHI-164 for TNF and B-9 for IL-6), while the BBB permeability was determined for a small (sodium fluorescein, molecular weight (MW) 376 Da), and a large (Evans' blue-albumin, MW 67000 Da) tracer by spectrophotometry in the parietal cortex, hippocampus, striatum, cerebellum and medulla of rats. The serum TNF level was significantly (P < 0.05) increased 6 and 24 h after the induction of pancreatitis, while the IL-6 level increased after 24 and 48 h. A significant (P < 0.05) increase in BBB permeability for both tracers developed at 6 and 24 h in different brain regions of animals with acute pancreatitis. We conclude that cytokines, such as TNF and IL-6, may contribute to the vasogenic brain edema formation during acute pancreatitis.
Assuntos
Barreira Hematoencefálica/fisiologia , Fluoresceína/farmacocinética , Interleucina-6/sangue , Pancreatite Necrosante Aguda/fisiopatologia , Fator de Necrose Tumoral alfa/metabolismo , Amilases/sangue , Animais , Encéfalo/irrigação sanguínea , Encéfalo/metabolismo , Edema Encefálico/fisiopatologia , Colagogos e Coleréticos , Modelos Animais de Doenças , Encefalite/etiologia , Encefalite/fisiopatologia , Azul Evans/farmacocinética , Masculino , Tamanho do Órgão , Pâncreas/metabolismo , Pâncreas/patologia , Pancreatite Necrosante Aguda/induzido quimicamente , Pancreatite Necrosante Aguda/complicações , Ratos , Ratos Wistar , Ácido TaurocólicoRESUMO
Tumor necrosis factor-alpha (TNF-alpha) plays a crucial role in the pathogenesis of the central nervous system infections. The aim of the present study was to analyze quantitatively the changes in the blood-brain barrier (BBB) permeability after the intracarotid injection of TNF-alpha. Recombinant human TNF-alpha was injected into the left internal carotid artery of anesthetized newborn pigs (n = 48) in the doses of 0, 1000, 10 000 and 100 000 IU, respectively. Before, as well as 1, 2, 4, 8, and 16 h after the challenge, the extravasation of a small (sodium fluorescein (SF), mw 376), and a large (Evan's blue-albumin (EBA), mw 67 000) tracer was determined concomitantly by spectrophotometry in the cerebral cortex of the animals. There was a time- and dose-dependent increase in BBB permeability both for SF and EBA; however, significant (P < 0.05) BBB opening for albumin only developed 2 h after the challenge. In the morphological study the same excitable tracers, identical experimental protocol and groups were used. Cryostat sections of brain tissue were viewed for optical sectioning with a confocal laser scanning microscope equipped with an argon/krypton ion laser. A diffuse BBB opening for SF and a moderate perivascular extravasation for EBA were found in the cortices of TNF-alpha-treated animals. We conclude that significant increases in intravascular TNF-alpha-concentration during neonatal infections may result in vasogenic brain edema formation.
Assuntos
Albuminas/farmacocinética , Barreira Hematoencefálica/efeitos dos fármacos , Azul Evans/farmacocinética , Fluoresceínas/farmacocinética , Fator de Necrose Tumoral alfa/farmacologia , Animais , Animais Recém-Nascidos , Artérias Carótidas , Córtex Cerebral/irrigação sanguínea , Córtex Cerebral/metabolismo , Córtex Cerebral/fisiopatologia , Relação Dose-Resposta a Droga , Edema/metabolismo , Edema/fisiopatologia , Feminino , Fluoresceína , Injeções Intra-Arteriais , Lasers , Masculino , Microscopia Confocal , Suínos , Fatores de TempoRESUMO
Tumor necrosis factor-alpha (TNF-alpha), a proinflammatory cytokine, has long been known to be involved in the pathogenesis of central nervous system infections and of certain neurodegenerative diseases. However, the possible role of the blood-brain barrier (BBB), the active interface between the blood circulation and brain tissue, remained unknown during these pathological conditions. In our in vitro reconstructed BBB model, 1-hr exposure of recombinant human TNF-alpha (in concentrations of 50, 250, and 500 U/ml, respectively) to the luminal membrane of bovine brain capillary endothelial cells (BBCEC) did not change significantly the transendothelial flux of either sucrose (m.w. 342 Da), or inulin (m.w. 5 kDa) up to 4 hr (early phase), except for a slight decrease (P < 0.05) in sucrose permeation at 2-4 hr with the highest dose of TNF-alpha. On the other hand, at 16 hr after the 1-hr challenge with TNF-alpha (delayed phase) at all 3 concentrations, significant increase was induced in the permeability of BBCEC monolayers for both markers. These changes of permeability were accompanied by a selective reorganization of F-actin filaments into stress fibers, while the intracellular distribution of vimentin remained similar to the control. These results suggest that BBCEC can respond directly to TNF-alpha by a delayed increase of permeability and reorganization of actin filaments.
Assuntos
Actinas/efeitos dos fármacos , Encéfalo/efeitos dos fármacos , Endotélio Vascular/efeitos dos fármacos , Permeabilidade/efeitos dos fármacos , Fator de Necrose Tumoral alfa/farmacologia , Animais , Astrócitos/efeitos dos fármacos , Barreira Hematoencefálica , Bovinos , Células Cultivadas , Membranas/efeitos dos fármacos , Microscopia Confocal , Sacarose/metabolismo , Fatores de TempoRESUMO
Second messengers, such as cyclic adenosine 3',5'-monophosphate (cAMP), have been shown to take part in the regulation of blood-brain barrier permeability. In the present study, elevation of cAMP levels decreased sucrose (mol. wt, 342) and inulin (mol. wt, 5000) permeability across monolayers of bovine brain capillary endothelial cells as early as 1 h after exposure. Since both tracers use predominantly a paracellular pathway, we assume that cAMP may increase the tightness of the tight junctions through protein phosphorylation.